A Roth1, J Beckmann2, K Bohndorf3,4, A Fischer5, C Heiß6, W Kenn7, M Jäger8, U Maus9, U Nöth10, K M Peters11, C Rader12, S Reppenhagen13, U Smolenski14, M Tingart15, I Kopp16, I Sirotin17, S J Breusch18. 1. Klinik und Poliklinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie; Bereich Endoprothetik/Orthopädie, Universitätsklinik Leipzig AöR, Liebigstraße 20, 04103, Leipzig, Germany. andreas.roth@medizin.uni-leipzig.de. 2. Sektion Endoprothetik, Sportklinik Stuttgart, Stuttgart, Germany. 3. Universitätsklinik für Radiologie und Nuklearmedizin, Exzellenzzentrum für Hochfeld MR, Medizinische Universität Wien, Vienna, Austria. 4. Christian Doppler Laboratory for Molecular Imaging, Medizinische Universität Wien, Vienna, Austria. 5. Abteilung für Physikalische und Rehabilitative Medizin, Klinikum Burgenlandkreis GmbH, Naumburg, Germany. 6. Klinik für Unfallchirurgie, Universitätsklinikum Gießen-Marburg, Marburg, Germany. 7. Institut für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Würzburg, Würzburg, Germany. 8. Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Essen-Duisburg, Essen, Germany. 9. Klinik für Orthopädie und orthopädische Chirurgie, Universitätsklinik für Orthopädie und Unfallchirurgie, Pius-Hospital, Oldenburg, Germany. 10. Klinik für Orthopädie und Unfallchirurgie, Evangelisches Waldkrankenhaus Spandau, Berlin, Germany. 11. Orthopädie und Osteologie, Dr. Becker Rhein-Sieg-Klinik, Nümbrecht, Germany. 12. Praxisklinik Orthopädie Aachen, Franziskushospital Aachen, Aachen, Germany. 13. Orthopädische Klinik König-Ludwig-Haus, Julius-Maximilians-Universität Würzburg, Würzburg, Germany. 14. Institut für Physiotherapie, Friedrich-Schiller Universität Jena, Jena, Germany. 15. Klinik für Orthopädie, Universitätsklinikum Aachen, Aachen, Germany. 16. AWMF-Institut, Philipps-Universität Marburg, Marburg, Germany. 17. Pirogov-Universität Moskau, 64. Städtisches Krankenhaus, Moscow, Russia. 18. FRCS Ed, Orthopaedic Department, Edinburgh Royal Infirmary, Edinburgh, UK.
Abstract
INTRODUCTION: The treatment of adult non-traumatic avascular necrosis of the femoral head (AVN; N-ANFH) within an estimated incidence of 5000-7000 cases per annum in Germany remains a challenge. Risk factors include steroids, alcohol abuse, chemotherapy and immunosuppressive medication, but a genetic predisposition has been suggested. Early diagnosis of this often bilateral disease process is essential for successful conservative or joint preserving surgical management. In this review, we present the update German consensus S3 guideline "diagnosis and management for N-ANFH" as a concise summary. MATERIALS AND METHODS: This systematic review is based on the published literature from January 1, 1970 to April 31, 2013 (German and English language). Inclusion criteria were systematic reviews, meta-analyses and relevant peer review publications. We identified a total of 3715 related publications, of which 422 were suitable according to the SIGN criteria, but only 159 fulfilled our inclusion criteria. RESULTS AND CONCLUSIONS: Clinical suspicion of N-ANFH mandates radiographic evaluation. If radiographs are normal MRI scans are recommended, which should be evaluated according to the ARCO-classification. Differential diagnoses include transient osteoporosis, bone bruise, insufficiency fracture and destructive arthropathy. Untreated, subchondral fractures commonly occur within 2 years, during which the risk for contralateral involvement is high-thereafter unlikely. Conservative management with Ilomedin and Alendronat can be tried, but other pharmacological or physical treatments are inappropriate. No specific joint preserving procedure can be recommended, but core decompression should be considered in early stages if necrosis is <30 %. In ARCO stages IIIc or IV total hip arthroplasty (THA) should be contemplated, which offers similar outcome compared to osteoarthritis. Young age is the main risk factor for higher revision rates after THA for N-ANFH.
INTRODUCTION: The treatment of adult non-traumatic avascular necrosis of the femoral head (AVN; N-ANFH) within an estimated incidence of 5000-7000 cases per annum in Germany remains a challenge. Risk factors include steroids, alcohol abuse, chemotherapy and immunosuppressive medication, but a genetic predisposition has been suggested. Early diagnosis of this often bilateral disease process is essential for successful conservative or joint preserving surgical management. In this review, we present the update German consensus S3 guideline "diagnosis and management for N-ANFH" as a concise summary. MATERIALS AND METHODS: This systematic review is based on the published literature from January 1, 1970 to April 31, 2013 (German and English language). Inclusion criteria were systematic reviews, meta-analyses and relevant peer review publications. We identified a total of 3715 related publications, of which 422 were suitable according to the SIGN criteria, but only 159 fulfilled our inclusion criteria. RESULTS AND CONCLUSIONS: Clinical suspicion of N-ANFH mandates radiographic evaluation. If radiographs are normal MRI scans are recommended, which should be evaluated according to the ARCO-classification. Differential diagnoses include transient osteoporosis, bone bruise, insufficiency fracture and destructive arthropathy. Untreated, subchondral fractures commonly occur within 2 years, during which the risk for contralateral involvement is high-thereafter unlikely. Conservative management with Ilomedin and Alendronat can be tried, but other pharmacological or physical treatments are inappropriate. No specific joint preserving procedure can be recommended, but core decompression should be considered in early stages if necrosis is <30 %. In ARCO stages IIIc or IV total hip arthroplasty (THA) should be contemplated, which offers similar outcome compared to osteoarthritis. Young age is the main risk factor for higher revision rates after THA for N-ANFH.
Entities:
Keywords:
AVN; Atraumatic avascular necrosis; Bisphosphonate; Bone grafting; Bone transplant; Core decompression; Diagnosis; Ilomedin; Total hip arthroplasty; Total hip replacement
Authors: Andreas Roth; Johannes Beckmann; Klaus Bohndorf; Christian Heiß; Marcus Jäger; Stefan Landgraeber; Uwe Maus; Ulrich Nöth; Klaus M Peters; Christof Rader; Stephan Reppenhagen; Ulrich Smolenski; Ina Kopp; Markus Tingart Journal: Orthopade Date: 2018-09 Impact factor: 1.087
Authors: G Diederichs; P Hoppe; F Collettini; G Wassilew; B Hamm; W Brenner; M R Makowski Journal: Skeletal Radiol Date: 2017-06-16 Impact factor: 2.199
Authors: Hiroto Inaba; Olga Varechtchouk; Michael D Neel; Matthew J Ehrhardt; Monika L Metzger; Seth E Karol; Kirsten K Ness; Raul C Ribeiro; Ching-Hon Pui; Mary V Relling; John T Sandlund; Sue C Kaste Journal: Pediatr Blood Cancer Date: 2020-05-30 Impact factor: 3.167
Authors: Michael A Mont; Hytham S Salem; Nicolas S Piuzzi; Stuart B Goodman; Lynne C Jones Journal: J Bone Joint Surg Am Date: 2020-06-17 Impact factor: 6.558